Agilent at ASMS 2026

Gary Patti is the Michael and Tana Powell Professor at Washington University in St. Louis, where he holds appointments in the departments of chemistry, genetics, and medicine. Dr. Patti is the Senior Director of the Center for Mass Spectrometry & Metabolic Tracing, Director of the Clinical Research Core in Medicine, Dean's Fellow of Advancement and Entrepreneurship, Director of Faculty Affairs, and the Chief Scientific Officer and Co-Founder of Panome Bio.  Professor Patti’s research focuses on developing and applying mass spectrometry-based technologies to enhance our understanding of cancer.  

Philip Lowenstern is a Product Marketing Director in Agilent’s Spectroscopy Division, based in Australia, with over 20 years of experience in analytical instrumentation. He leads global product strategy for atomic spectroscopy and collaborates closely with customers and R&D teams worldwide to deliver nextgeneration ICPMS and spectroscopy hardware and software platforms. 

Mark Kelinske is an ICP-MS Product Specialist at Agilent Technologies with over 20 years of experience in analytical chemistry. He specializes in advanced ICP-MS and ICP-MS/MS techniques, supporting laboratories across a wide range of applications.  His expertise includes method development, instrument optimization, troubleshooting complex analytical challenges, and helping laboratories improve performance and efficiency in their analytical workflows. 

Brian Rivera is a software product manager at Agilent Technologies with over 20 years of experience in HPLC analysis of large molecules, including LC/MS for oligonucleotides and monoclonal antibodies. As a software product manager, his focus is on the practical implementation of innovative data analysis in regulated labs. 

Andreas Otto is Director of Strategic Product Management for LC and LC/MS at Agilent. He joined Agilent in 2018 and brings more than ten years of experience in highresolution LC/MS, with a strong background in bioanalytics and proteomics. Andreas holds a PhD in Microbiology and is a trained biochemist. 

Russell is a dedicated leader with a proven track record of success in the development and commercialization of automation, instrumentation, and software products for life science and industrial applications. Currently, he serves as a Technical Product Manager at Agilent Technologies, where he has been working full-time since March 2023. Based in Santa Clara, California, Russell manages LC/SQ and LC/TOF Mass Spectrometer products. 

Melissa Sato brings over 15 years of biopharma experience specializing in analytical sciences, including mass spectrometry and chromatography for mAbs, BiTEs, fusion proteins, and oligonucleotides. She brings over 10 years of experience in Multi-Attribute Method expanding across development to GMP from her roles at Amgen and Thermo Fisher Scientific.  At Amgen, she was an integral part of implementing MAM in GMP and co-authored a patent on sequential enzymatic digestion for MS analysis. Now at Agilent, Melissa leads the MAM for OpenLab CDS product and oversees BioConfirm and ExDViewer, driving innovation in biopharma mass spectrometry applications.

Jahziel Chase is a PhD candidate in Chemistry and Chemical Biology at Northeastern University, based in the Biopharmaceutical Analysis Training Laboratory (BATL) within Northeastern's Center for Bioinnovation. His research focuses on developing protein characterization methods using multiple ion mobility–mass spectrometry platforms to streamline biopharmaceutical quality control workflows. He is National GEM Fellow, LSAMP scholar, and NeU STARS Fellow. Jahziel has founded the Northeastern University chapter of NOBCChE and leads the NOBCChE Boston City Collaborative, where he works to build community and opportunity for scientists in the Boston area. 

Jeff McDonald has been involved with small-molecule chromatography and mass spectrometry for almost 30 years.  He received a B.S. in Chemistry from Fort Lewis College in 1996 and a Ph.D. in Analytical Chemistry in the lab of Ron Hites at Indiana University in 2002.  After postdoctoral training and a short stint as a Reseach Chemist at the FBI Research Lab in Quantico, VA, he returned to academic research at UT Southwestern Medical Center in Dallas, TX.  There, he has spent the last 21 years building a world-class lipid mass spectrometry research laboratory.  Recently, neurodegeneration/exposome project brought him back to his graduate school roots of measuring organochlorine pesticides.   

Alan Owens is the GC Product Manager at Agilent Technologies, where he leads product strategy and development for Agilent’s highend gas chromatography solutions. With a decade of experience in the chromatography industry, Alan is passionate about advancing analytical capabilities and supporting scientists across a wide range of applications. He holds a B.S. in Chemistry and Biology from HampdenSydney College. 

Lakshmi Krishnan is the GC/MS Single Quadrupole Product Manager at Agilent Technologies. Based in Santa Clara, she leads product development and portfolio management for Agilent’s GC/MSD platform. She holds an M.S. in Biotechnology with a Business Administration focus from San Jose State University, bridging scientific expertise with product leadership. 

Jeremy Koelmel is an Associate Research Faculty at Yale where he focuses on software and methdologies for non-targeted analysis. He is also CEO of Innovative Omics, where he provides trainings on state-of-the-art lipidomics, PFAS, polymer, and small molecule analysis. He has worked with Agilent for over 15 years on both open-source and vendor software to aid Agilent customers to get the most from their data.

Devin Peterson is a CFAES Distinguished Professor at The Ohio State University and a leading expert in flavor science. He pioneered flavoromics, a molecular to sensory framework that identifies chemical drivers of flavor perception, and his research spans taste, smell, somatosensation, and flavor modulation to improve food quality and consumer acceptance. He has received multiple national awards, founded the Flavor Research and Education Center, directs the OSU Foods for Health Initiative, and has published more than 125 peer‑reviewed articles.

Matthew Wong is an engineer in the PAT and Digital Applications team in Single-Use and Integrated Process Solutions R&D at MilliporeSigma. His work focuses on leveraging LCMS for online process analytics, such as monitoring mAb glycosylation, and on digital network integration to enable advanced control and data-driven insights. Matthew earned his B.S. in Chemical and Biomolecular Engineering from the University of Delaware and his Ph.D. in Chemical and Biological Engineering from Rensselaer Polytechnic Institute.

Rob was the founding CEO and is the current President and CSO of Molecular You Corporation. Backed by his expertise in molecular diagnostics, molecularly targeted drug discovery and development, biochemistry and regulatory compliance, Rob Fraser drives the innovation behind Molecular You’s multi-biomarker analytics. He established a low-cost method of measuring hundreds of biomarkers from a single blood sample, along with establishing a LLM model to incorporate the world’s leading scientific literature. 

Dr. Christoph Borchers is a Full Professor in the Gerald Bronfman Department of Oncology at McGill University, and Director of the Segal Cancer Proteomics Centre. He currently holds the Segal-McGill Chair in Molecular Oncology and is a Fellow of the Canadian Academy of Health Sciences. Dr. Borchers is recognized as a pioneer and leading figure in the development of mass spectrometry-based methods for protein quantification using Multiple Reaction Monitoring (MRM) and structural proteomics.

David Mast began his career at the University of Illinois at Urbana–Champaign, where he developed multimodal mass‑spectrometry workflows for the stereochemical characterization of neuropeptides. He later conducted his postdoctoral research at Pacific Northwest National Laboratory, applying quantitative bottom‑up proteomics to elucidate protein ubiquitination pathways in Alzheimer’s disease. He is currently a Principal Analytical Chemist at Corden Pharma Colorado, specializing in MS‑based structural characterization of synthetic peptides and the integration of advanced MS techniques into analytical pipelines for pharmaceutical peptide manufacturing and process development.

Dr. Nicholas Lentz, Senior Analytics Manager for Birchtech, has more than 20 years of experience conducting mercury and water research and tests (PFAS and other analytes), both in the lab and in the field with over 75 full-scale test programs and numerous bench- and pilot test projects. Dr. Lentz manages Birchtech’s Analytic Design Center operations, which included the analysis and expert assessment of various contaminant and water sources. 

Phil is a Research Professor in the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope, where his team is developing and implementing multi-omic technologies to advance the frontiers of metabolomics, lipidomics, proteomics, and microbiomics. His background and training are in chemistry and pharmacology. Over the past two decades, he directed metabolomics and proteomics core facilities, authored 130 peer-reviewed publications, and contributed to high-impact discoveries that span the continuum of basic to clinical research. He is also an international best-selling book author (The Hidden Half: Your Microbiome's Untold Story of Health, Aging, and Vitality).

Rachel is an Application Development Scientist at Agilent Technologies, where she advances biopharmaceutical analysis through innovative mass spectrometry workflows. She joined Agilent in 2023 following the acquisition of e‑MSion, bringing hands‑on expertise with the technology that now powers the Agilent ExD cell. Her work focuses on peptide and protein characterization using high‑resolution MS, with emphasis on impurity profiling and structural elucidation of therapeutic peptides, including GLP‑1 receptor agonists.

Nick Birse is an assistant professor at Queen’s University Belfast, UK, based within the Institute for Global Food Security. His research focuses on the application of mass spectrometry combined with chemometrics and machine learning to address critical challenges in food authenticity and food safety. 

Dr. Fei Yu is an Institute Senior Research Scientist in Therapeutic Discovery at UT MD Anderson Cancer Center. She applies a broad range of innovative technologies to uncover new starting points for some of the most challenging cancer drug targets. Her research aims to transform these discoveries into next-generation cancer therapies.

Mark earned his Ph.D. from Colorado State University, where he used mass spectrometry to characterize Mycobacterium tuberculosis glycoproteins and later developed LC/MS methods to profile Mtb lipids during his postdoctoral work. He subsequently joined the Institute for Systems Biology (Seattle, WA) as a Research Scientist, designing MS-based approaches to measure metabolites and lipids across diverse projects. Since joining Agilent in 2012, Mark has developed a wide range of targeted and untargeted mass‑spectrometry–based metabolomics and lipidomics applications, with an emphasis on integrated hardware and software workflows.